Literature DB >> 3049185

Effect of doxycycline on pre-menstrual syndrome: a double-blind randomized clinical trial.

A Toth1, M L Lesser, G Naus, C Brooks, D Adams.   

Abstract

Thirty patients with well-defined symptoms of pre-menstrual syndrome were randomly treated with the antibiotic doxycycline or placebo. The antibiotic-treated group showed a highly significant reduction of symptoms. Subsequent antibiotic treatment of the original placebo group similarly diminished the symptoms in this group. A 6-month follow-up demonstrated that the improvement in symptom scores was permanent and independent from the presence of the antibiotic. Luteal phase endometrial biopsies showed a high incidence of out-of-phase endometrium. An unexpectedly high percentage of endometrial biopsy cultures yielded positive findings for mycoplasma, Chlamydia trachomatis and anaerobic bacteria. There were no characteristic hormonal changes in this study group. An infectious aetiology, possibly a sub-clinical endometrial or ovarian infection, behind certain cases of pre-menstrual syndrome is postulated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049185     DOI: 10.1177/030006058801600404

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  5 in total

1.  Sexually Transmitted Pathogens, Depression, and Other Manifestations Associated with Premenstrual Syndrome.

Authors:  Caroline Doyle; Walker A Swain; Holly A Swain Ewald; Christine L Cook; Paul W Ewald
Journal:  Hum Nat       Date:  2015-09

2.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

3.  Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis.

Authors:  Chenju Yi; Zhiyuan Zhang; Wei Wang; Caroline Zug; Hermann J Schluesener; Zhiren Zhang
Journal:  Neurochem Res       Date:  2011-06-08       Impact factor: 3.996

4.  Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3.

Authors:  Yuri Cho; Hyo Jin Son; Eun-Mee Kim; Ji Hyun Choi; Sung Tae Kim; In Jung Ji; Dong Hee Choi; Tong H Joh; Yoon Seong Kim; Onyou Hwang
Journal:  Neurotox Res       Date:  2009-07-07       Impact factor: 3.911

5.  Were there evolutionary advantages to premenstrual syndrome?

Authors:  Michael R Gillings
Journal:  Evol Appl       Date:  2014-08-11       Impact factor: 5.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.